Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 1,484.00p on 28-03-2025 at 12:00:31
Change 6.50p 0.44%
Buy 1,484.00p
Sell 1,483.50p
Buy / Sell GSK Shares
Last Trade: Buy 79.00 at 1,484.00p
Day's Volume: 878,941
Last Close: 1,477.50p
Open: 1,478.00p
ISIN: GB00BN7SWP63
Day's Range 1,476.50p - 1,491.00p
52wk Range: 1,282.50p - 1,820.00p
Market Capitalisation: £60,341m
VWAP: 1,483.2143p
Shares in Issue: 4,066m

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 79 1,484.00p Automatic Execution
12:00:31 - 28-Mar-25
Sell* 162 1,484.00p Automatic Execution
12:00:31 - 28-Mar-25
Sell* 1,435 1,484.00p Automatic Execution
12:00:31 - 28-Mar-25
Sell* 360 1,484.00p Automatic Execution
12:00:31 - 28-Mar-25
Sell* 90 1,484.50p Automatic Execution
12:00:30 - 28-Mar-25
Sell* 120 1,484.50p Automatic Execution
12:00:30 - 28-Mar-25
Sell* 303 1,484.50p Automatic Execution
12:00:30 - 28-Mar-25
Sell* 950 1,484.50p Automatic Execution
12:00:30 - 28-Mar-25
Sell* 807 1,484.50p Automatic Execution
12:00:30 - 28-Mar-25
Buy* 343 1,484.50p Automatic Execution
12:00:30 - 28-Mar-25
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
28th Mar 2025 (Fri) 1,478.00 1,491.00 1,476.50 1,477.50 878,941
27th Mar 2025 (Thu) 1,473.00 1,480.00 1,464.50 1,477.50 5,389,674
26th Mar 2025 (Wed) 1,483.00 1,484.00 1,454.50 1,475.50 6,531,583
25th Mar 2025 (Tue) 1,487.50 1,512.50 1,485.50 1,486.00 9,503,975
24th Mar 2025 (Mon) 1,517.00 1,517.00 1,481.00 1,485.00 7,646,885
21st Mar 2025 (Fri) 1,514.00 1,529.00 1,504.50 1,509.00 20,824,638
20th Mar 2025 (Thu) 1,503.00 1,522.50 1,500.50 1,511.00 13,843,563
19th Mar 2025 (Wed) 1,518.50 1,522.00 1,492.00 1,505.00 10,068,194
18th Mar 2025 (Tue) 1,538.00 1,540.50 1,529.00 1,531.50 8,141,376
17th Mar 2025 (Mon) 1,515.00 1,537.50 1,509.50 1,536.00 6,922,146
14th Mar 2025 (Fri) 1,499.50 1,514.00 1,495.50 1,511.00 7,108,565
13th Mar 2025 (Thu) 1,490.00 1,508.50 1,485.00 1,499.00 11,176,571
12th Mar 2025 (Wed) 1,516.50 1,523.50 1,486.00 1,490.00 9,995,163
11th Mar 2025 (Tue) 1,547.50 1,558.50 1,505.50 1,516.00 13,727,549
10th Mar 2025 (Mon) 1,529.00 1,560.50 1,527.50 1,558.50 26,728,500
7th Mar 2025 (Fri) 1,506.00 1,535.50 1,497.00 1,534.00 8,913,668
6th Mar 2025 (Thu) 1,482.00 1,507.50 1,474.00 1,500.50 10,557,543
5th Mar 2025 (Wed) 1,487.50 1,495.00 1,475.00 1,483.00 7,700,757
4th Mar 2025 (Tue) 1,474.00 1,524.50 1,474.00 1,509.00 9,446,387
3rd Mar 2025 (Mon) 1,468.50 1,496.00 1,467.50 1,479.50 6,544,526
28th Feb 2025 (Fri) 1,462.50 1,478.50 1,460.50 1,466.50 18,308,593
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
27th Mar 2025 7:00 am RNS Transaction in Own Shares
26th Mar 2025 7:00 am RNS Transaction in Own Shares
25th Mar 2025 4:34 pm RNS GSK uUTI treatment approved by US FDA
25th Mar 2025 7:00 am RNS Transaction in Own Shares
24th Mar 2025 4:10 pm RNS Notice of AGM
24th Mar 2025 7:05 am RNS EMA Filing acceptance for Nucala COPD
24th Mar 2025 7:00 am RNS Transaction in Own Shares
21st Mar 2025 3:30 pm RNS Director/PDMR Shareholding
21st Mar 2025 7:00 am RNS Transaction in Own Shares
20th Mar 2025 7:00 am RNS Transaction in Own Shares
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

IN BRIEF: Haleon initiates first tranche of GBP330 million buyback

28th Mar 2025 08:48

Haleon PLC - Weybridge, Surrey-based consumer healthcare firm that spun out of GSK PLC in 2022 - Commences up to GBP330 million share buyback programme. Says this represents the remainder of the GBP500 million allocated to buybacks in 2025, announced as part of its 2024 results in February. It follows the completion of Haleon's off-market repurchase of 44.2 million shares from Pfizer Inc for approximately GBP170 million, announced in March. Says the first tranche is for an up to GBP200 million consideration, commencing immediately and to end no later than June 26 this year. Haleon expects the buyback scheme to enhance its earnings per share, with Goldman Sachs hired to carry out the purchase of shares. Read More

GSK urinary tract infection drug Blujepa approved by US regulator

25th Mar 2025 18:30

(Alliance News) - GSK on Tuesday said its urinary tract infection treatment gepotidacin, under the brand name Blujepa, has been approved in the US. Read More

GSK has application to expand use of mepolizumab accepted by EMA

24th Mar 2025 08:28

(Alliance News) - GSK PLC on Monday said it has had an application to expand the use of mepolizumab for the treatment of chronic obstructive pulmonary disease accepted for review by the European Medicines Agency. Read More

LONDON BRIEFING: FTSE 100 called up ahead of further US-Russia talks

24th Mar 2025 07:54

(Alliance News) - London's FTSE 100 is called to open higher on Monday, ahead of a slew of flash composite readings later in the day, and following the announcement of UK plans to cut government Civil Service spending. Read More

CORRECT: London opens lower ahead of Fed rate decision

19th Mar 2025 08:26

(Clarifies that M&G's assets under management are in billions, not millions.) Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value8,682.49
Change16.37

Login to your account

Forgot Password?

Not Registered